What We Offer
Advisory Services
Beyond capital, we provide strategic guidance and hands-on support to help our portfolio companies navigate the complex journey from innovation to market.
What We Do
Our Advisory Services
Comprehensive capital, advisory, and innovation solutions for life sciences and biopharma
BD&L Advisory
End-to-end business development and licensing support — from target identification and diligence through valuation, negotiation, and deal execution.
M&A Transactions
Strategic advisory on mergers, acquisitions, and divestitures, including buy-side and sell-side mandates across the biopharma and life sciences landscape.
Capital Raise
Structuring and execution of equity and debt financings, including venture capital, private equity, venture debt, and other non-dilutive financing solutions.
Commercial Strategy
Holistic commercial guidance across Value & Access, go-to-market, growth marketing, Medical Affairs, and payer and provider functions.
Primary Market Research
Proprietary research and data-driven insights to validate hypotheses, size markets, and inform strategic decisions across therapeutic areas.
Corporate Advisory
Shareholder value maximization, portfolio optimization, restructuring, and performance improvement to strengthen organizational positioning.
Why 11Scientific
What Sets Us Apart
Four pillars that define how we deliver value to every client engagement
Integrated Model
We combine investment banking rigor with deep scientific expertise — providing clients with a 360° view across deal structuring, clinical strategy, and commercial execution.
Sector Focus
Exclusively focused on life sciences, biopharma, medical devices, and health-tech — giving us unmatched depth across therapeutic areas, modalities, and ecosystem stakeholders.
Data-Driven Insights
Proprietary accelerators, primary research capabilities, and analytical frameworks that surface actionable intelligence from complex scientific and commercial data sets.
Execution Agility
Lean, senior-led teams that move quickly from strategy to execution — reducing friction at every stage of the transaction or advisory process.
Core Capabilities
Our Expertise
Comprehensive solutions across capital, advisory, and innovation
Capital
- Mergers & Acquisitions
- Licensing
- Capital Raise
- IPO Planning
- Private Capital
- Venture Debt
- Other Non-Dilutive Financing
Advisory
- BD&L Advisory
- Corporate Advisory
- Shareholder Value Maximization
- Portfolio Advisory
- Product Advisory
Innovation
- Asset / Platform Technology Build-out
- New Product Development
- Restructuring and Performance Improvement
- Ecosystem Development
Our Process
BD&L Advisory Process
A structured, six-stage approach to business development and licensing engagements
Strategy & Scoping
Define objectives, asset profile, and target partnership criteria
Target Identification
Map the landscape using proprietary databases and primary research
Outreach & Engagement
Senior-led outreach to qualified counterparties and key decision-makers
Diligence & Valuation
Scientific, commercial, and financial diligence with rigorous NPV modelling
Negotiation & Structuring
Term sheet development, deal structuring, and negotiation support
Close & Post-Deal
Transaction execution, regulatory filings, and post-close integration support
Work With Us
Partner With Us
If you're building a transformative life science company, we'd love to hear from you.
Get in Touch